A Director at Rocket Pharmaceuticals Inc (RCKT) is Selling Shares


Yesterday, a Director at Rocket Pharmaceuticals Inc (RCKT), David Southwell, sold shares of RCKT for $588.9K.

This is Southwell’s first transaction since reporting a Buy transaction on TCRD back in December 2010 In addition to David Southwell, one other RCKT executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Currently, Rocket Pharmaceuticals Inc has an average volume of 179K.

In the last 30 days, insiders have sold $588.9K worth of RCKT shares and purchased $85.01K worth of RCKT shares.

David Southwell’s trades have generated a -2.6% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, devastating diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts